[{"Assets_0_Q1_USD":221319000.0,"CommonStockSharesOutstanding_0_Q1_shares":469453883.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-50607000.0,"NetIncomeLoss_1_Q1_USD":-43218000.0,"StockholdersEquity_0_Q1_USD":-150583000.0,"Ticker":"NVAX","CIK":"1000694","name":"NOVAVAX INC","OfficialName":"Novavax Inc. Common Stock","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4164288206.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20190502"}]